Because there are reports on cytotoxic and cytoprotective effects of antipsychotics, the aim of the present study was to evaluate the impacts of different concentrations (1.6—50 μg/mL) of atypical antipsychotics on the survival of human neuronal (neuroblastoma SH-SY5Y) and immune (monocytic U-937) cells and on energy metabolism (ATP level after the incubation with antipsychotics in the concentration of 25 μg/mL). Statistical analysis showed that incubation for 24 h with the antipsychotics quetiapine, risperidone, 9-hydroxyrisperidone and ziprasidone led to a significantly enhanced cell survival in both cell lines in the lower concentrations. Higher concentrations exerted in part cytotoxic effects with the exception of quetiapine, but therapeutically relevant concentrations of the drugs were not cytotoxic in our experiments. Measurement of ATP contents in the neuronal cell line showed significantly increased levels after a 24-h treatment with 25 μg/mL risperidone and 9-hydroxyrisperidone. The other substances produced no effects. Our results show that the antipsychotic substances under investigation exert concentration-dependent effects on cell survival in both cell lines examined.
Agostinho, FR, Jornada, LK, Schröder, N., Roesler, R., Dal-Pizzol, F., Quevedo, J. ( 2007) Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain. Neurochem Res32: 1343-1350.
2.
Aito, H., Aalto, KT, Raivio, KO ( 2004) Adenine nucleotide metabolism and cell fate after oxidant exposure of rat cortical neurons: effects of inhibition of poly (ADP-ribose) polymerase. Brain Res1013: 117-124.
3.
Andreoli, SP, Mallett, CP ( 1997) Disassociation of oxidant-induced ATP-depletion and DNA damage from early cytotoxicity in LLC-PK1 cells. Am J Physiol272: F729-F735.
4.
Bai, O., Wie, Z., Lu, W., Bowen, R., Keegan, D., Li, X-M. ( 2002) Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. J Neurosci Res69: 278-283.
5.
Behl, C., Rupprecht, R., Skutella, T., Holsboer, F. ( 1995) Haloperidol-induced cell death-mechanism and protection with vitamin E in vitro. Neuroreport7: 360-364.
6.
Deicken, RF, Calabrese, G., Merrin, EL, Fein, G., Weiner, MW ( 1995) Basal ganglia phosphorous metabolism in chronic schizophrenia . Am J Psychiatry152: 126-129.
7.
Fehsel, K., Loeffler, S., Krieger, K., Henning, U., Agelink, M., Kolb-Bachofen, V., et al. (2005) Clozapine induces oxidative stress and proapoptotic gene expression in neutrophils of schizophrenic patients. J Clin Psychopharmacol25: 419-426.
8.
Fujimoto, T., Nakano, T., Takano, T., Hokazono, Y., Asakura, T., Tsuji, T. ( 1992) Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand86: 455-462.
9.
Fukuzako, H. ( 2001) Neurochemical investigation of the schizophrenic brain by in vivo phosphorus magnetic resonance spectroscopy. World J Biol Psychiatry2: 70-82.
10.
Gil-ad, I., Shtaif, B., Shiloh, R., Weizman, A. ( 2001) Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms . Cell Mol Neurobiol21: 705- 716.
11.
Heiser, P., Enning, F., Krieg, J-C., Vedder, H. ( 2007) Effects of haloperidol, clozapine and olanzapine on the survival of human neuronal and immune cells in vitro. J Psychopharm21: 851-856.
12.
Klöcking, R., Schacke, M., Wutzler, P. ( 1995) Primärscreening antiherpetischer Verbindungen mit EZ4U. Chemotherapie J4: 141-147.
13.
Lohr, JB, Kuczenski, R., Bracha, HS, Moir, M., Jeste, DV ( 1990) Increased indices of free radical activity in the cerebrospinal fluid of patients with tarditive dyskinesia. Biol Psychiatry28: 535-539.
14.
Maurer, I., Möller, HJ ( 1997) Inhibition of complex I by neuroleptics in normal human brain cortex parallels the extrapyramidal toxicity of neuroleptics. Mol Cell Biochem174: 255-259.
15.
Morgenstern, H., Glazer, WM ( 1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale tardive dyskinesia study. Arch Gen Psychiatry50: 723-733.
16.
Peet, M., Laugharne, J., Rangarajan, N., Reynolds, GP ( 1993) Tarditive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol8: 151-153.
17.
Pettegrew, JW, Keshavan, MS, Panchalingam, K., Strychor, S., Kaplan, DB, Tretta, MG, et al. (1991) Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics: a pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry48: 563-568.
18.
Polydoro, M., Schröder, N., Lima, MNM, Caldana, F., Laranja, DC, Bromberg, E., et al. (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav78: 751- 756.
19.
Qing, H., Xu, H., Wei, Z., Gibson, K., Li, X-M. ( 2003) The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci17: 1563-1570.
20.
Reinke, A., Martins, MR, Lima, MS, Moreira, JC, Dal-Pizzol, F., Quevedo, J. ( 2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett372: 157-160.
21.
Sagara, Y. ( 1998) Induction of reactive oxygen species in neurons by haloperidol . J Neurochem71: 1002-1012.
22.
Skinner, TE, O’Donnell, JM, Roitaille, PM, Nasrallah, HA ( 1995) 31P MRS study of clozapine vs. haloperidol effects on brain metabolism. Biol Psychiatry37: 648[abstract].
23.
Sunderland, T., Cohen, BM ( 1987) Blood to brain distribution of neuroleptics. Psychiatry Res20: 299-305.
24.
Tan, Q-R., Wang, X-Z., Wang, C-Y., Liu, X-J., Chen, Y-C., Wang, H-H., et al. (2007) Differential effects of classical and atypical antipsychotic drugs on rotenone induced neurotoxcity in PC12 cells. Eur Neuropsychopharmacol17: 768-773.
25.
Teepker, M., Anthes, N., Fischer, S., Krieg, J-C., Vedder, H. ( 2007) Effects of oxidative challenge and calcium on ATP-levels in neuronal cells. Neurotoxicology28: 19-26.
26.
Tsai, G., Goff, DC, Chang, RW, Flood, J., Baer, L., Coyle, JT ( 1998) Markers of glutamergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry155: 1207- 1213.
27.
Tsuneizumi, T., Babb, SM, Cohen, BM ( 1992) Drug distribution between blood and brain as a determinant of antipsychotic drug effects. Biol Psychiatry32: 817-824.
28.
Ukai, W., Ozawa, H., Tateno, M., Hashimoto, E., Saito, T. ( 2004) Neurotoxic potential of haloperidol in comparison with risperidone: implication of Akt-mediated signal changes by haloperidol . J Neural Transm111: 667-681.
29.
Vairetti, M., Feletti, F., Battaglia, A., Pamparana, F., Canonico, PL, Richelmi, P., et al. (1999) Haloperidol-induced changes in glutathione and energy metabolism: effect of nicergoline. Eur J Pharmacol367: 67-72.
30.
Volz, HP, Rzanny, R., Rossger, G., Hubner, G., Kreitschmann-Andermahr, I., Kaiser, WA, et al. (1997) Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study. Psychiatry Res76: 123-129.
31.
Volz, HP, Riehemann, S., Maurer, I., Smesny, S., Sommer, M., Rzanny, R., et al. (2000) Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a 31P chemical shift spectroscopic-imaging study. Biol Psychiatry47: 954-961.
32.
Wang, H., Xu, H., Dyck, LE, Li, X-M. ( 2005) Olanzapine and quetiapine protect PC12 cells from β-amyloid peptide 25-35-induced oxidative stress and the ensuing apoptosis . J Neurosci Res81: 572- 580.
33.
Wang, J., Green, PS, Simpkins, JW ( 2001) Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive oxygen species induced by 3-nitroproprionic acid in SK-N-SH human neuroblastoma cells. J Neurochem77: 804-811.
